Trial Profile

A STUDY INVESTIGATES NEW CARE MODEL OF SHORTER HOSPITAL STAY FOLLOWED BY AT-HOME TREATMENT WITH SC2WEAR SUBCUTANEOUS FUROSEMIDE

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 18 Jul 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

18 Jul 2017 New trial record
24 Jan 2017 According to a scPharmaceuticals media release, Five centers are participating in the pilot phase including Emory University Hospital, Massachusetts General Hospital, Mayo Clinic, Duke University Medical Center and Metro Health System. The main study is expected to include up to an additional 20 centers in the US and the Michael Felker, MD, Duke University is the principal investigator.
24 Jan 2017 According to a scPharmaceuticals media release, Enrollment for the pilot phase started in January of 2017 and the anticipated read out of the SUBQ-HF study program is in 2018.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com